LegoChem, riding ADC sugar rush, raises $411M from confectionery company
LegoChem Bioscience, fresh from fattening up on Johnson & Johnson’s cash, has found a way to feed its growing sweet tooth. Responding to the antibody-drug conjugate (ADC) sugar rush, the Korean biotech has secured 548.5 billion South Korean won ($411 million) from confectionery company Orion to support the expansion of its R&D pipeline.